NEA
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


CuspAI announces £335m Series B led by Kleiner Perkins and NEA to design new semiconductor, energy and advanced manufacturing materials
CuspAI builds an agentic AI platform, MIRA, that designs new materials to order, running the full cycle from generative design through simulation, synthesis planning and coordinated lab validation. The platform serves industrial and government R&D teams in semiconductors, clean energy and advanced manufacturing, where the materials needed for next-generation products do not yet exist.


Valarian raises a £37m Series A round led by NEA to provide sovereign control over AI workloads
Valarian is a sovereign infrastructure company whose platform applies workload-level governance across the environments where critical applications, AI systems and operational workloads run. Enforced at the infrastructure layer and inherited automatically by every deployed capability, that governance determines how those systems communicate, access data and operate for enterprises, sovereign nations and defence programmes.


Synthesia announces a £150m Series E led by Google Ventures to develop new conversational agents to support workplace learning
Synthesia creates AI-generated video tools for businesses, enabling organisations to produce training, learning and internal communications content using digital avatars and interactive, conversational video experiences.


CuspAI raises £75m Series A led by NEA and Temasek to accelerate AI-driven materials discovery
CuspAI applies generative AI and physics based simulation to design new materials, helping customers discover compounds faster for applications in energy, climate, computing and manufacturing.


Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
Charm Therapeutics develops next generation cancer drugs designed to overcome treatment resistance, using an AI driven discovery platform to identify compounds for aggressive blood cancers such as AML.


Synthesia secures £150m in Series D funding led by NEA to advance AI video for enterprise communications
Synthesia develops enterprise video software that allows companies to create, localise and personalise video communications at scale, supporting internal training, product education and global knowledge sharing without traditional production costs.
More venture news
- 29 Jul 2026

GreyparrotGreyparrot raises £20m Series B from angels for AI camera systems that read waste on recycling belts
Series BClimate - 29 Jul 2026

QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences - 28 Jul 2026


Dwelly lands £130m in funding led by EQT Growth and General Catalyst to acquire and run independent lettings agencies on shared AI infra
Series BProperty